Floatz logo

Yttrium-90

Radioembolization

Derek W. CoolradiopharmaceuticalPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Radioembolization cohort.

Asset / SponsorPhaseRating
Theprubicin
Eastern Hepatobiliary Surgery Hospital
N/AD
Ethiodized Oil
Eastern Hepatobiliary Surgery Hospital
N/AD

Same molecule, other indications

Yttrium-90 is also rated in:

hepatocellular carcinomaDormant
B
Indicative ·
58 / 100
View asset →
hepatocellular carcinomaDormant
B
Indicative ·
58 / 100
View asset →
Liver Cancer (Locally Advanced or Metastatic)Dormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →